Elypta: Eva Pisa

Swedish cancer detection firm Elypta has appointed Eva Pisa to its board. She founded Sangtec Molecular Diagnostics, where she also served as its CEO before Cepheid, now part of Danaher, acquired the firm. Pisa also was with Roche Diagnostics, where she was most recently an SVP before she retired. She currently serves on the boards of several biotechnology companies.